|
RBBP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.19824158875781E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62470037423645E-12 |
| Normal-vs-Stage2 |
2.34609999999469E-05 |
| Normal-vs-Stage3 |
8.023900E-03 |
| Normal-vs-Stage4 |
2.499700E-02 |
| Stage1-vs-Stage2 |
3.030200E-01 |
| Stage1-vs-Stage3 |
1.431710E-02 |
| Stage1-vs-Stage4 |
1.094580E-01 |
| Stage2-vs-Stage3 |
2.146000E-01 |
| Stage2-vs-Stage4 |
4.872800E-01 |
| Stage3-vs-Stage4 |
7.245400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63247193540883E-12 |
| Normal-vs-AfricanAmerican |
9.05919783633635E-11 |
| Normal-vs-Asian |
8.036000E-02 |
| Caucasian-vs-AfricanAmerican |
8.237800E-01 |
| Caucasian-vs-Asian |
6.115600E-01 |
| AfricanAmerican-vs-Asian |
7.019400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62492241884138E-12 |
| Normal-vs-Female |
2.20679999995976E-06 |
| Male-vs-Female |
3.776400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.89669999951204E-07 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
3.6015002091716E-10 |
| Normal-vs-Extreme_Obese |
1.135850E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.768100E-02 |
| Normal_Weight-vs-Obese |
9.192200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.862800E-01 |
| Extreme_Weight-vs-Obese |
6.302100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.328200E-01 |
| Obese-vs-Extreme_Obese |
9.299000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.698420E-02 |
| Normal-vs-Age(41-60Yrs) |
5.18363130197486E-13 |
| Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(81-100Yrs) |
2.61690003000581E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.981440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.687500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.738500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.380830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.800600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.625600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.05480000003977E-06 |
| Normal-VS-KIRP CIMP |
6.403600E-01 |
| Normal-VS-Unclassified PRCC |
1.67589999655604E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.162020E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.136400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.862400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.937700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.179200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.859200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.47040166101442E-11 |
| Normal-vs-N1 |
1.363430E-01 |
| Normal-vs-N2 |
1.793370E-01 |
| N0-vs-N1 |
1.900100E-03 |
| N0-vs-N2 |
6.022800E-01 |
| N1-vs-N2 |
3.914200E-01 |
|
|
